These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15615632)

  • 1. Recent advances in experimental modeling of the assembly of tau filaments.
    Ko LW; DeTure M; Sahara N; Chihab R; Vega IE; Yen SH
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):125-39. PubMed ID: 15615632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic.
    Dujardin S; Colin M; Buée L
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):59-80. PubMed ID: 25428793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
    Brandt R; Hundelt M; Shahani N
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tauopathies with transgenic mice.
    Hutton M; Lewis J; Dickson D; Yen SH; McGowan E
    Trends Mol Med; 2001 Oct; 7(10):467-70. PubMed ID: 11597522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations causing neurodegenerative tauopathies.
    Goedert M; Jakes R
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse models of tauopathy in drug discovery.
    Noble W; Hanger DP; Gallo JM
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):403-28. PubMed ID: 20522014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
    Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
    J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Animal models of tauopathies].
    Higuchi M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tau protein in both physiological and pathological conditions.
    Avila J; Lucas JJ; Perez M; Hernandez F
    Physiol Rev; 2004 Apr; 84(2):361-84. PubMed ID: 15044677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies.
    Clavaguera F; Grueninger F; Tolnay M
    Neuropharmacology; 2014 Jan; 76 Pt A():9-15. PubMed ID: 24050961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
    Williams DR
    Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-tocopherol on an animal model of tauopathies.
    Nakashima H; Ishihara T; Yokota O; Terada S; Trojanowski JQ; Lee VM; Kuroda S
    Free Radic Biol Med; 2004 Jul; 37(2):176-86. PubMed ID: 15203189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.
    Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
    Am J Pathol; 2003 Jan; 162(1):213-8. PubMed ID: 12507904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two days of tau: a meeting focused on its biology and pathology.
    Skoulakis EM; Mudher A
    Biochem Soc Trans; 2010 Aug; 38(4):953-4. PubMed ID: 20658983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].
    Sánchez MP; Alvarez-Tallada V; Avila J
    Rev Neurol; 2001 Jul 16-31; 33(2):169-77. PubMed ID: 11562878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on tauopathies.
    Lebouvier T; Pasquier F; Buée L
    Curr Opin Neurol; 2017 Dec; 30(6):589-598. PubMed ID: 28914736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryo-EM structures of tau filaments.
    Scheres SH; Zhang W; Falcon B; Goedert M
    Curr Opin Struct Biol; 2020 Oct; 64():17-25. PubMed ID: 32603876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.